| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
0.9 |
| mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
0.9 |